
Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered ... Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all class I isoforms of PI3K and mammalian target of rapamycin (mTOR). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.11 | -1.01289134438 | 10.86 | 11.13 | 9.51 | 130920 | 10.60551057 | CS |
4 | -0.3 | -2.7149321267 | 11.05 | 11.66 | 9.51 | 179550 | 10.71641668 | CS |
12 | 0.92 | 9.35910478128 | 9.83 | 11.66 | 7.575 | 277400 | 9.9187445 | CS |
26 | -1.91 | -15.0868878357 | 12.66 | 14.19 | 7.575 | 264525 | 11.10208208 | CS |
52 | -5.69 | -34.6107055961 | 16.44 | 19.77 | 7.575 | 296181 | 13.86286111 | CS |
156 | 5.09 | 89.9293286219 | 5.66 | 22.188 | 5.66 | 164199 | 13.65153744 | CS |
260 | 2.23 | 26.1737089202 | 8.52 | 33.01 | 4.81 | 133615 | 15.3814981 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.